JP2013539454A5 - - Google Patents

Download PDF

Info

Publication number
JP2013539454A5
JP2013539454A5 JP2013519096A JP2013519096A JP2013539454A5 JP 2013539454 A5 JP2013539454 A5 JP 2013539454A5 JP 2013519096 A JP2013519096 A JP 2013519096A JP 2013519096 A JP2013519096 A JP 2013519096A JP 2013539454 A5 JP2013539454 A5 JP 2013539454A5
Authority
JP
Japan
Prior art keywords
seq
antibody
dnnnnrps
afiwydgsnkyyadsvkgr
arysgwyfdy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013539454A (ja
JP5992406B2 (ja
Filing date
Publication date
Priority claimed from GBGB1011771.1A external-priority patent/GB201011771D0/en
Application filed filed Critical
Publication of JP2013539454A publication Critical patent/JP2013539454A/ja
Publication of JP2013539454A5 publication Critical patent/JP2013539454A5/ja
Application granted granted Critical
Publication of JP5992406B2 publication Critical patent/JP5992406B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2013519096A 2010-07-13 2011-07-13 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用 Expired - Fee Related JP5992406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1011771.1 2010-07-13
GBGB1011771.1A GB201011771D0 (en) 2010-07-13 2010-07-13 Biological material and particular uses thereof
PCT/EP2011/061983 WO2012007516A1 (en) 2010-07-13 2011-07-13 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016074000A Division JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Publications (3)

Publication Number Publication Date
JP2013539454A JP2013539454A (ja) 2013-10-24
JP2013539454A5 true JP2013539454A5 (enExample) 2014-03-20
JP5992406B2 JP5992406B2 (ja) 2016-09-14

Family

ID=42712312

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013519096A Expired - Fee Related JP5992406B2 (ja) 2010-07-13 2011-07-13 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用
JP2016074000A Pending JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016074000A Pending JP2016175906A (ja) 2010-07-13 2016-04-01 再発した癌患者の治療におけるｉｃａｍ−１に対する抗体の使用

Country Status (10)

Country Link
US (2) US20130189260A1 (enExample)
EP (1) EP2593481A1 (enExample)
JP (2) JP5992406B2 (enExample)
KR (1) KR20130100977A (enExample)
CN (1) CN103003308B (enExample)
AU (1) AU2011278350B2 (enExample)
CA (1) CA2805200A1 (enExample)
GB (1) GB201011771D0 (enExample)
RU (1) RU2593709C2 (enExample)
WO (1) WO2012007516A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525214D0 (en) 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof
GB2495113A (en) * 2011-09-29 2013-04-03 Bioinvent Int Ab Anti-ICAM-1 antibody for treating multiple-myeloma-related disorders
KR20150088853A (ko) 2012-11-29 2015-08-03 바이엘 헬스케어 엘엘씨 활성화 단백질 c에 대한 인간화 모노클로날 항체 및 그의 용도
EP2925351A4 (en) * 2012-11-29 2016-08-24 Bayer Healthcare Llc MONOCLONAL ANTIBODIES DIRECTED AGAINST ACTIVATED PROTEIN C (APC)
GB201300346D0 (en) * 2013-01-09 2013-02-20 Biolnvent Internat Ab BiologIcal materials and uses thereof
US20170173005A1 (en) 2014-03-27 2017-06-22 Research Foundation Of The City University Of New York Method for detecting or treating triple negative breast cancer
KR101674874B1 (ko) 2014-10-21 2016-11-22 한국원자력의학원 항암제 내성 예측용 바이오마커로서의 ｉｃａｍ－３ 및 이의 용도
US9795624B2 (en) 2015-05-04 2017-10-24 Research Foundation Of The City University Of New York Cationic polymers as co-drugs for chemotherapeutic agents
US11077187B2 (en) 2015-11-17 2021-08-03 Oklahoma Medical Research Foundation Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof
BR112018014069A2 (pt) * 2016-01-12 2018-12-11 Univ Southern California uso de uma dieta de reforço e imitação de jejum, uso de uma dieta de reforço e imitação de jejum com um agente quimioterápico, e pacote de dieta.
CA3024272A1 (en) 2016-05-11 2017-11-16 University Of Southern California Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
EP3595636A4 (en) 2017-03-16 2021-01-13 Children's Medical Center Corporation ENGINEERED LIPOSOMES USED AS THERAPEUTIC AGENTS TARGETING CANCER
CN109949256B (zh) * 2019-01-14 2023-04-07 昆明理工大学 一种基于傅里叶变换的天文图像融合方法
MX2021009142A (es) 2019-02-06 2021-10-13 Venthera Inc Inhibidores topicos de fosfoinositol 3-cinasas.
JP2023535280A (ja) * 2020-07-20 2023-08-17 エフエヌシーティー バイオテック、インコーポレイテッド 大腸癌転移阻害剤をスクリーニングする方法
JP2023538265A (ja) * 2020-08-04 2023-09-07 ベンセラ，インコーポレイティド ホスホイノシチド３－キナーゼ阻害剤の製剤
KR20230107115A (ko) 2022-01-07 2023-07-14 서울대학교병원 항-icam-1 항체의 단기요법을 이용한 간이식 거부반응의 억제방법
AU2024305352A1 (en) 2023-06-12 2025-12-04 Amgen Inc. Lymphotoxin beta receptor agonist binding proteins
KR20250179879A (ko) 2024-06-24 2025-12-31 서울대학교병원 항-icam-1 항체를 유효성분으로 포함하는 비알콜성 지방간 또는 비알콜성 지방간염 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ZA883159B (en) * 1987-05-04 1990-01-31 Dana Farber Cancer Inst Inc Intercellular adhesion molecules and their binding ligands
US5643872A (en) 1989-10-23 1997-07-01 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US6008058A (en) 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
GB9701425D0 (en) 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
GB0525214D0 (en) * 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof
US20110045060A1 (en) * 2008-02-29 2011-02-24 Shinshu University Kit for detecting cancer cells metastasizing into sentinel lymph node
GB0903151D0 (en) * 2009-02-25 2009-04-08 Bioinvent Int Ab Antibody uses and methods

Similar Documents

Publication Publication Date Title
JP2013539454A5 (enExample)
JP2012126742A5 (enExample)
CY1122278T1 (el) Αντι il-36r αντισωματα
JP2017048194A5 (enExample)
JP2011182796A5 (enExample)
JP2014518898A5 (enExample)
JP2018504907A5 (enExample)
JP2017176174A5 (enExample)
JP2014064590A5 (enExample)
RU2018132044A (ru) Антитела против тау
JP2010227108A5 (enExample)
JP2012034696A5 (enExample)
JP2011155981A5 (enExample)
JP2012102113A5 (enExample)
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
JP2016525888A5 (enExample)
PH12016500859A1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
JP2013510581A5 (enExample)
GEAP202114794A (en) Antibody neutralizing human respiratory syncytial virus
JP2014051497A5 (enExample)
JP2009225798A5 (enExample)
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
CA2872308A1 (en) Novel ha binding agents
JP2012136541A5 (enExample)
JP2012507294A5 (enExample)